… with dementia with Lewy bodies (clumps of alpha-synuclein) compared to other types of dementia. The study was funded in part by … the disease." Read more about this study. Maggie Kuhl Vice President Patient Engagement …

… Join one of our free in-person events to connect with your local community and learn about Parkinson’s research taking place … your backyard. Read more and find a list of cities we’ll be visiting in 2023 below. To ensure a spot, early registration …

… Parkinson's Awareness Month got off to an early start this year with an official bump from the … trials to advance knowledge of the disease; and (5) commends the dedication of local and regional organizations, … how you can get involved in Parkinson's Awareness Month, visit  www.michaeljfox.org/ . Lauren Shoor …

… in drug development. However, Jonathan's sense of urgency to find cures intensified after he received a diagnosis of … at age 49. In recent years, the genetic target GBA has come to the forefront of Parkinson's disease (PD) research. … to see if you qualify to participate. Allison Boiles Vice President Communications …

… LRRK2 (Leucine-Rich Repeat Kinase 2) is a protein thought to be involved in regulating signaling pathways in cells. … of interest and then used to determine, for example, where that protein resides in the body or how its levels … development of this assay from Invitrogen ( www.invitrogen.com ), Neuromab ( www.neuromab.org ) and Epitomics, Inc. ( …

… Today, Biotie Therapies is announcing positive clinical … of the drug. They have partnered with pharmaceutical company UCB, and will discuss next steps in early 2013. … drug targeting adenosine in the third phase of clinical testing .  Other researchers investigating adenosine’s role …